1-1 of 1
Emma MC Driessen, MD
Close
Sort by
Journal Articles

MEK Inhibition Is a Promising Therapeutic Strategy for MLL -Rearranged Infant ALL Patients Carrying RAS Mutations

Mark JB Kerstjens, MSc, Emma MC Driessen, MD, Merel Willekes, BSc, Sandra S Mimoso Pinhancos, MSc, Rob Pieters, MD PhD, Ronald Stam, PhD
Journal: Blood
Blood (2014) 124 (21): 919.
https://doi.org/10.1182/blood.V124.21.919.919
Published: 2014